The National Institute of Allergy and Infectious Diseases is one of the 27 institutes and centers that make up the National Institutes of Health (NIH), an agency of the United States Department of Health and Human Services (HHS). NIAID's mission is to conduct basic and applied research to better understand, treat, and prevent infectious, immunologic, and allergic diseases.
Maine Medical Center is a 637 licensed-bed teaching hospital for Tufts University School of Medicine, and previously Robert Larner College of Medicine, located at 22 Bramhall Street in Portland, Maine, United States with a staff of over 6,000 people. The facility has obtained the rating of Level I Trauma Center, one of only three in Northern New England. Founded in 1874, it is the largest hospital in northern New England with 28,000 inpatient visits, about 500,000 outpatient visits, 88,000 emergency visits, and over 27,000 surgeries performed annually. MMC is structured as a non-profit, private corporation governed by volunteer trustees.
Harvey James Alter is an American medical researcher, virologist, physician and Nobel Prize laureate, who is best known for his work that led to the discovery of the hepatitis C virus. Alter is the former chief of the infectious disease section and the associate director for research of the Department of Transfusion Medicine at the Warren Grant Magnuson Clinical Center in the National Institutes of Health (NIH) in Bethesda, Maryland. In the mid-1970s, Alter and his research team demonstrated that most post-transfusion hepatitis cases were not due to hepatitis A or hepatitis B viruses. Working independently, Alter and Edward Tabor, a scientist at the U.S. Food and Drug Administration, proved through transmission studies in chimpanzees that a new form of hepatitis, initially called "non-A, non-B hepatitis" caused the infections, and that the causative agent was probably a virus. This work eventually led to the discovery of the hepatitis C virus in 1988, for which he shared the Nobel Prize in Physiology or Medicine in 2020 along with Michael Houghton and Charles M. Rice.
Thomas Clark Chalmers, MD, FACP was famous for his role in the development of the randomized controlled trial and meta-analysis in medical research.
The Health Sciences Center for Global Health (HSCGH) at The Ohio State University (OSU) is a collaborative program among the OSU Colleges of Dentistry, Medicine, Nursing, Optometry, Pharmacy, Public Health, School of Health and Rehabilitation Sciences and Veterinary Medicine. The HSCGH is led jointly by the Colleges of Medicine (COM) and Public Health (CPH).
Richard Alan Cash, M.D., M.P.H. is an American global health researcher, public health physician, and internist. He is a Senior Lecturer in International Health at the Harvard T.H. Chan School of Public Health in Boston. Cash began his international career over 40 years ago when he was assigned by NIAID of the NIH to the Pakistan-SEATO Cholera Research Laboratory (CRL) in Dhaka, East Pakistan. While there, he and his colleagues developed and conducted the first clinical trials of oral rehydration therapy (ORT) in adult and pediatric cholera patients and patients with other infectious causes of diarrhea. This technology matches the volume of fluid losses from dehydration patients with the volume they consume so that the fluid replacement packets greatly reduce or completely replace IV therapy, which was then the only current treatment for cholera. Discoveries in ORT have been estimated to have saved over 50 million lives worldwide. World Health Organization (WHO) estimates are that at least 60 million children have been spared painful deaths because of ORT. They also conducted the first field trials of ORT, the first community-based trials of ORT, and the first use of amino acids (glycine) as an additional substrate. In the late 1970s, Cash worked with BRAC on their OTEP, which taught over 13 million mothers and caregivers how to prepare and use ORT in the home using the "pinch and scoop" method.
Robert Palmer Beasley was a physician, public health educator and epidemiologist whose work on hepatitis B involved extensive investigations in Taiwan. That work established that hepatitis B virus (HBV) is a primary cause of liver cancer and that hepatitis B virus is transmitted from mother to infant during childbirth. Beasley and his colleagues also proved that HBV mother-to-infant transmission is preventable by at-birth vaccination. Due to this work, the World Health Assembly designated HBV as the seventh global vaccine in 1992. He later became the author of HBV immunization policies for the World Health Organization.
Andrew D. Luster is the Persis, Cyrus and Marlow B. Harrison Professor of Medicine at Harvard Medical School, and the Chief of the Division of Rheumatology, Allergy and Immunology at Massachusetts General Hospital. He is Director of its Research Center for Immunology and Inflammatory Diseases, and a member of the Dana-Farber/Harvard Cancer Center's Cancer Immunology program.
Sujal M. Parikh (1985–2010) was an American global health advocate, University of Michigan medical student, and an NIH-Fogarty Clinical Research Scholar. His research and advocacy efforts focused on access to medicines in developing countries, health and human rights. He died of injuries from a motorcycle taxi accident in Uganda in 2010. An annual symposium at the University of Michigan honors his life's work.
Stuart Blank Levy was a researcher and physician at Tufts University. He was among the first to advocate for greater awareness of antibiotic resistance and founded the Alliance for the Prudent Use of Antibiotics.
Vivian Winona Pinn is an American physician, scientist, and pathologist known for her advocacy of women's health issues and concerns, particularly for ensuring that federally funded medical studies include female patients, and well as encouraging women to follow medical and scientific careers. Before her retirement in 2011, she had served as associate director for research on women's health at the National Institutes of Health (NIH), and had directed NIH's Office of Research on Women's Health. Pinn also previously taught at Harvard University and Tufts University in Massachusetts, as well as Howard University College of Medicine in Washington, D.C. Since retiring from NIH, Pinn has continued working as a senior scientist emerita at NIH's Fogarty International Center.
Barry R. Bloom is Harvard University Distinguished Service Professor and Joan L. and Julius H. Jacobson Professor of Public Health in the Department of Immunology and Infectious Diseases and Department of Global Health and Population in the Harvard T.H. Chan School of Public Health in Boston, where he served as dean of the faculty from 1998 through December 31, 2008.
Simin Liu is an American physician researcher. He holds leadership positions internationally in the research of nutrition, genetics, epidemiology, and environmental and biological influences of complex diseases related to cardiometabolic health in diverse population. His research team has uncovered new mechanisms and risk-factors as well as developed research frameworks for diabetes and cardiovascular diseases. Liu's laboratory conducts research mainly in the United States, though the group has had research collaborations, teaching, and service activities in six of the Seven Continents.
John I. Gallin is an American medical researcher who has contributed to the understanding of innate immunity but especially chronic granulomatous disease, a phagocyte disorder. Gallin was appointed director of the NIH Clinical Center on May 1, 1994, and served until January 8, 2017. He serves as the chief scientific officer for the Clinical Center and associate director for Clinical Research at the National Institutes of Health.
Roger I. Glass is an American physician-scientist who serves as the Director of the John E. Fogarty International Center.
John Eugene Bennett is an American physician-scientist. He is a senior investigator in the clinical mycology section in the intramural research program at the National Institute of Allergy and Infectious Diseases.
Anita Kaniz Mehdi Zaidi is a Pakistani physician and the Director of Vaccine Development at the Bill & Melinda Gates Foundation. She has previously served as Professor of Paediatrics and Child Health at the Aga Khan University.
Nahid Bhadelia is an American infectious-diseases physician, an associate professor at the Boston University School of Medicine, and the medical director of the Special Pathogens Unit at Boston Medical Center.
Emily J. Erbelding is an American physician-scientist. She is the director of the Division of Microbiology and Infectious Diseases at the National Institute of Allergy and Infectious Diseases (NIAID). Erbelding was previously deputy director of the Division of AIDS at NIAID. She was a faculty member at Johns Hopkins School of Medicine and served as director of clinical services for the Baltimore City Health Department STD/HIV program.
Shuchi Anand is an Indian-American nephrologist and clinical researcher investigating chronic kidney disease, tubulointerstitial disease, and global health. She is an assistant professor of medicine at the Stanford University Medical Center.
